Improvement of social functioning in patients with first-episode schizophrenia using blonanserin treatment

A prospective, multi-centre, single-arm clinical trial

Bibliographic Data

ID15525159
AuthorsTian-Qi Gao (Peking University Sixth Hospital), Hong Deng (0000-0002-6033-0162, West China Hospital of Sichuan University), Jianhua Sheng (Shanghai Jiao Tong University), Bin Wu (0000-0002-7568-1993, Xian Mental Health Center), Zhening Liu (0000-0001-6893-2427, Central South University), Fude Yang (0009-0003-8171-6181, Beijing HuiLongGuan Hospital), Lina Wang (0009-0002-3877-4928, Tianjin Anding Hospital), Shaohua Hu (0000-0003-0570-670X, First Affiliated Hospital Zhejiang University), Xijin Wang (Harbin Medical University), Haiyun Li (0000-0001-6803-4117, Sumitomo Dainippon Pharma (Japan)), Chengcheng Pu (0000-0002-1117-9531, Peking University, corresponding author), Xin Yu (0000-0003-3983-4937, Peking University, corresponding author)
Year2024
Volume15
Pages1345978-1345978
Publication date2024-03-20
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2024.1345978
PMID38571994
OpenAlexW4393026385
LanguageEN
References cited4

Blonanserin treatment exhibited favourable effects on social functioning in individuals with first-episode schizophrenia. The results suggest that blonanserin was effective treatment options for patients with schizophrenia encountering functional impairments

Adverse effect · Clinical endpoint · Clinical trial · Cognition · Global Assessment of Functioning · Neurocognitive · Positive and Negative Syndrome Scale · Psychiatry · Psychosis · Rating scale · Schizophrenia (object-oriented programming · Advanced Neuroimaging Techniques and Applications · Medicine · Psychology · Schizophrenia research and treatment · Tryptophan and brain disorders · Internal Medicine

Tools

Open DOIOpen Access